Top Markets
Coin of the day
Sigyn Therapeutics, Inc. Sigyn Therapeutics, Inc.

Sigyn Therapeutics, Inc.

SIGY
Rang in Aktien #41050
Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise... Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise currently in its development phase. The company's core innovation is Sigyn Therapy, an advanced blood purification system designed to overcome the limitations of existing drugs and medical devices used to treat severe inflammatory disorders. A key focus is on sepsis, which represents a major cause of hospital-related deaths. Furthermore, Sigyn Therapeutics is actively evaluating the potential of Sigyn Therapy to address a broad spectrum of other therapeutic targets, including bacterial endotoxins, peptidoglycan, and lipoteichoic acid; various viral pathogens; harmful hepatic toxins; CytoVesicles; and significant pro-inflammatory cytokines such as tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6. The company is headquartered in San Diego, California.
Aktienkurs
$0.03
Zuletzt synchronisiert: 2026-08-12
Marktkapitalisierung
$48.16K
Veränderung (1 Tag)
-23.08%
Veränderung (1 Jahr)
-98.93%
Land
US
Handel Sigyn Therapeutics, Inc. (SIGY)

Kategorie

Dividendenrendite-Verlauf für Sigyn Therapeutics, Inc. (SIGY)
Dividendenrendite (TTM) von Sigyn Therapeutics, Inc. (Aktienkürzel: SIGY) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Sigyn Therapeutics, Inc. (SIGY) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber